Nabla Valuation, Funding & Investors
Nabla is valued at $180M as of January 2024.
Last Nabla valuation
$180M
Series B · Jan 2024
Last Nabla funding round
$70M
Series C · Jun 2025
Cumulative funding Nabla raised
$115M
across 3 funding rounds
Key investors in Nabla
Cathay Innovation
HV Capital
DST Global
Highland Europe
ARVO VENTURE CAPITAL
ZEBOX Ventures
About Nabla
Nabla is a Paris-headquartered healthcare AI company developing tools for radiology and pathology diagnostics. Its platform uses deep learning models integrated into PACS systems to detect abnormalities in X-rays, CT scans, and histopathology slides. Nabla partners with hospitals in Europe and the US to reduce diagnostic errors and reading times by up to 30 percent.
Founded
2018
HQ
ParisWebsite
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Valuation
$180M (Jan 2024)
Nabla Valuation
Nabla is currently valued at $180M, based on its Series B in January 2024.
The $24M round was led by Cathay Innovation, with participation from ZEBOX Ventures.
Nabla valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Jan 2024 | Series B | $180M |
Nabla Funding History
Nabla has raised a total of $115M across 3 funding rounds.
Nabla's first fundraising round was a $21M Series A in April 2021. The most recent completed round was a $70M Series C in June 2025.
Nabla funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jun 2025 | Series C | HV Capital (lead); Highland Europe; Build Collective; Cathay Innovation; DST Global | $70M | - | Nabla Technologies, founded by Alex LeBrun, Delphine Groll, and Martin Raison, develops an AI-powered clinical assistant platform that embeds intelligent support into clinician workflows, offering ambient listening, dictation, coding, and EHR commands to reduce documentation time. The platform integrates with major EHRs like Epic, Cerner, and athenahealth, supports over 35 languages, and serves more than 85,000 clinicians across over 130 healthcare organizations, including CVS Health, Children’s Hospital Los Angeles, and rural hospitals. It handles over 20 million annual patient encounters and is evolving from clinical documentation to an agentic AI model for broader workflow automation, billing, and efficiency in various care settings. On June 17, 2025, Nabla raised $70 million in its Series C funding round, led by HV Capital with participation from Highland Europe, DST Global, Cathay Innovation, and Build Collective, bringing total funding to $120 million. The capital will accelerate product development toward agentic AI, support national growth, and deepen integration into clinical workflows. This follows a $24 million Series B in January 2024 at a reported $180 million valuation, with the company noting revenue multiplied by five over the past six months prior to the Series C. Nabla's rapid scaling has earned praise for its enterprise-grade product, accuracy, and execution speed, positioning it as a pioneer in clinical AI amid clinician burnout and productivity challenges. It competes in a heating ambient AI market against players like Abridge, Ambience, Suki, and Nuance, with strong traction in academic centers, safety-net hospitals, and physician groups. Leadership includes Dr. Ed Lee as Chief Medical Officer, with advisors like Yann LeCun and Tony Fadell. |
| Jan 2024 | Series B | Cathay Innovation (lead); ZEBOX Ventures | $24M | $180M | Nabla is a Paris-based healthcare AI startup that develops Nabla Copilot, an ambient AI assistant designed to help medical practitioners with clinical documentation and administrative tasks. Launched in March 2023, Copilot automatically generates clinical notes and medical reports, allowing doctors and clinicians to spend more time on patient care rather than administrative work. The platform is powered by internally developed large language models with input from former Meta AI engineers, and Yann LeCun serves as an adviser. Nabla announced a $24 million Series B funding round on January 5, 2024, led by Cathay Innovation with participation from ZEBOX Ventures (the corporate VC arm of CMA CGM). This brought the company's total funding to over $43 million. Following the round, Nabla achieved a post-money valuation of $180 million. By the time of the Series B announcement, Nabla Copilot had achieved significant traction with over 20,000 providers adopting the solution across the US and worldwide. The platform was closely integrated with major electronic health record systems including Epic and Nextgen, and was already processing more than 3 million clinical encounters per year across 3 languages. The Series B capital was allocated toward expanding the platform's capabilities and adoption within U.S. healthcare systems, adding new language support, and solidifying market leadership in AI-assisted clinical documentation. |
| Apr 2021 | Series A | ARVO VENTURE CAPITAL | $21M | - | - |
Who has invested in Nabla?
7 investors have backed Nabla across its funding rounds, including Cathay Innovation, HV Capital, DST Global, Highland Europe, ARVO VENTURE CAPITAL and ZEBOX Ventures.
Lead investors include HV Capital and Cathay Innovation.
Nabla Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
 San Francisco, CA | 2 | Lead | Jan 2024 | |
 London | 1 | Participant | Jun 2025 | |
| Paris | 1 | Participant | Jun 2025 | |
| Marseille | 1 | Participant | Jan 2024 | |
 Munich | 1 | Lead | Jun 2025 | |
This data is available for Pro users. Sign up to see all 7 Nabla investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialNabla Competitors
Nabla competitors include listed companies like Airdoc, JLK and Ever Fortune.AI, and private ones like RapidAI, Zus Health and ElMindA.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| San Francisco, CA | Private | - | - | $234M | - | |
 China | Publicly listed | $26M | ($3M) | $127M | 1.5x | |
| Boston, MA | Private | - | - | $190M | - | |
 South Korea | Publicly listed | $2M | ($9M) | $92M | - | |
 Herzliya | Private | - | - | $173M | - | |
 Taiwan | Publicly listed | $12M | $4M | $158M | - |
Nabla Public Comps
Nabla is still privately-owned, but its public comps include Carasent, eWeLL, CE Holdings, Bioneer, Exagen, Perfect Corp., Kusurinomadoguchi, Ever Fortune.AI, Cmes Robotics and Fortifai.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $35M | $9M | 5.2x | 4.4x | 19.4x | 19.9x | |||
| $22M | $11M | 7.6x | 6.5x | 15.7x | 13.2x | |||
| $102M | $18M | 1.5x | 1.5x | 8.1x | - | |||
| $240M | $16M | 0.8x | - | 12.5x | - | |||
| $67M | ($13M) | 2.9x | 2.7x | (14.4x) | (27.4x) | |||
| $69M | $636K | 0.5x | 0.5x | 56.9x | 11.9x | |||
| $79M | $27M | 2.4x | 2.2x | 7.1x | 6.6x | |||
| $12M | $4M | 12.3x | - | 36.2x | - | |||
This data is available for Pro users. Sign up to see all Nabla competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Nabla
| When was Nabla founded? | Nabla was founded in 2018. |
| Where is Nabla headquartered? | Nabla is headquartered in Paris, France. |
| Is Nabla publicly listed? | No, Nabla is a private, VC-backed company. |
| What is Nabla's valuation? | Nabla was last valued at $180M in its Series B in January 2024. |
| How much funding has Nabla raised? | Nabla has raised $115M across 3 funding rounds. |
| What was Nabla's last funding round? | Nabla's last funding round was a $70M Series C in June 2025, led by HV Capital. |
| Who are Nabla's investors? | Nabla's investors include Cathay Innovation, Highland Europe, Build Collective, ZEBOX Ventures, HV Capital, ARVO VENTURE CAPITAL and DST Global. |
| Which companies are comparable to Nabla? | Companies comparable to Nabla include RapidAI, Airdoc, Zus Health, JLK, ElMindA and Ever Fortune.AI. |
See companies similar to Nabla
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.